The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Codexis Inc’s stock clocked out at $2.44, up 2.09% from its previous closing price of $2.39. In other words, the price has increased by $2.09 from its previous closing price. On the day, 0.65 million shares were traded. CDXS stock price reached its highest trading level at $2.4653 during the session, while it also had its lowest trading level at $2.335.
Ratios:
To gain a deeper understanding of CDXS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.72. In the meantime, Its Debt-to-Equity ratio is 1.20 whereas as Long-Term Debt/Eq ratio is at 1.14.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 12 ’25 when Opaleye Management Inc. bought 100,000 shares for $2.25 per share. The transaction valued at 225,000 led to the insider holds 12,100,000 shares of the business.
Opaleye Management Inc. bought 99,102 shares of CDXS for $220,997 on Jun 13 ’25. The 10% Owner now owns 12,199,102 shares after completing the transaction at $2.23 per share. On Jun 16 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 50,898 shares for $2.24 each. As a result, the insider paid 114,012 and bolstered with 12,250,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 202141312 and an Enterprise Value of 201857424. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.06 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 4.052 whereas that against EBITDA is -3.252.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.52, which has changed by -0.15570933 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is 3.07%, while the 200-Day Moving Average is calculated to be -28.58%.
Shares Statistics:
It appears that CDXS traded 887.40K shares on average per day over the past three months and 959540 shares per day over the past ten days. A total of 82.84M shares are outstanding, with a floating share count of 80.17M. Insiders hold about 3.23% of the company’s shares, while institutions hold 83.15% stake in the company. Shares short for CDXS as of 1749772800 were 6355406 with a Short Ratio of 7.16, compared to 1747267200 on 5730222. Therefore, it implies a Short% of Shares Outstanding of 6355406 and a Short% of Float of 7.8099996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
